medigraphic.com
ISSN 1560-4381 (Print)

2014, Number 4

<< Back Next >>

Correo Científico Médico 2014; 18 (4)

Misoprostol en la inducción del aborto temprano

Serrano AA, Concepción FL

Language: Spanish
References: 12
Page: 700-708
PDF size: 245.66 Kb.


ABSTRACT

Introduction: the medical abortion is an effective option in the intentional and outpatient abortion in the first trimester.
Objective: to demonstrate the efficacy of misoprostol in end of pregnancy.
Method: an intervention study was performed in adolescents and women who were attended at Curettage service of "Vladimir I. Lenin" Hospital, Holguin, to end their pregnancy by the pharmacological method, with the use of misoprostol in doses of 600 mg. The universe / sample comprised 31 women who gave their informed consent, as well as the consent of the Maternal and Child Deputy Director. Criteria approved by the Ministry of Health for the use of vaginal misoprostol for induction of abortion were considered. Variables were studied such as: maternal age, time to expulsion, complications and outcome of the intervention.
Results: predominated pregnant adolescents and young women, the most common age ranges were between 20 and 29 years (64.5%) and 15 to 19 with 32.3%, mainly from Holguin municipality. After misoprostol, the largest number of cases, 27 (87.1%) aborted within 12 hours.
Conclusions: the use of vaginal misoprostol was an effective and reliable method as an alternative to abortion in the first trimester.


REFERENCES

  1. Távara Orozco L, Chávez Alvarado S. Regulación del uso obstétrico del misoprostol en los países de América Latina y El Caribe. Rev Per Ginecol Obstet. 2013[citado 24 abr 2013]; 59(2) Disponible en: http://www.scielo.org.pe/scielo.php?pid=S2304-51322013000200002&script=sci_arttext

  2. Grimes D, Bencon J, Singh S, Romero M, Ganatra B, Okonofua F, et al. Unsafe abortion: the preventable pandemic. Lancet. 2006 [citado 24 abr 2013]; 368 (9550): 1908–919. Disponible en: http://www.sciencedirect.com/science/article/pii/S0140673606694816

  3. Behnamfar F, Mahdian M, Rahimi F, Samimi M. Misoprostol Abortion: Ultrasonography versus Beta-hCG testing for verification of effectiveness. Pak J Med Sci. 2013[citado 8 may 2014]; 29(6): 1367–70. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905382/

  4. Cuba. Ministerio de Salud Pública. Aborto farmacológico con misoprostol. Orientaciones metodológicas. La Habana: MINSAP; 2008.

  5. Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011 [citado 8 may 2014]; 9(11). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22071804

  6. Ngoc NT, Shochet T, Blum J, Hai PT, Dung DL, Nhan TT, et al. Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting. BMC Pregnancy Childbirth. 2013 [citado 2 may 2014]; 13: Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704810/

  7. Say L, Brahmi D, Kulier R, Gülmezoglu M, Campana A. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev. 2002 [citado 5 abr 2014]; 4. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003037.pub2/abstract;jsessionid=1DDF4094B40A5FA90D6B391E83DD738C.f02t04

  8. Miller SE, Lehman T, Campbell M, Hemmerling A, Anderson SB, Rodríguez H, et al. Misoprostol and declining abortion-realted morbidity in Santo Domingo, Dominican Republic: a temporary association. Br J Obstet Gynaecol.2005 [citado 5 abr 2014]; 112:1291-6. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1471-0528.2005.00704.x/pdf

  9. Aramide TM, Olusegun AK, Akinfolarin AC, Oriola DF. Oral misoprostol in the prevention of uterine bleeding after surgical evacuation of first trimester abortion: a comparative study of three uterotonic agents. Niger J Clin Pract. 2014 [citado 6 may 2014]; 17(1): 10-3. Disponible en: http://www.njcponline.com/article.asp?issn=1119-3077;year=2014;volume=17;issue=1;spage=10;epage=13;aulast=Aramide

  10. Rojas Quintana P, Ayo Naranjo P, Jorge Fernández A, Sotolongo Castro I, Hernández Cabrera J, Najarro A. Efectividad del misoprostol para el aborto en el primer trimestre del embarazo en adolescentes. Medisur. 2008[citado 2 may 2014]; 6(1). Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/353

  11. Alam A, Bracken H, Johnston HB, Raghavan S, Islam N, Winikoff B, et al. Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. Int Perspect Sex Reprod Health. 2013 [citado 14 feb 2013]; 39(2). Disponible en: http://www.guttmacher.org/pubs/journals/3907913.html

  12. Carménate Martínez L, Coronado Mestre RE, Hernández Rodríguez JM, Sánchez Texidor C. Reacciones adversas del misoprostol por vía vaginal en el aborto farmacológico. MEDICIEGO. 2010 [citado 12 may 2013]; 16(1). Disponible en: http://bvs.sld.cu/revistas/mciego/vol16_01_10/articulos/t-8.html




2020     |     www.medigraphic.com